GIP and Hyperglycemia: We next explored the possibility that treatment of WT mice with mouse [D-Ala2]GIP (41, 44), a relatively stable GIP analog (45, 46), could reduce STZ-induced hyperglycemia in a fashion similar to that observed with STZ+DCZ-treated K-GsD mice.